Goserelin

2005/01/01 by Susan M. Cheer, Susan M Cheer, Greg L Plosker +4 · 11 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Adjuvant #Breast Cancer Treatment Studies #Breast cancer #Cancer #Chemotherapy #Estrogen and related hormone effects #Goserelin #Gynecology #HER2/EGFR in Cancer Research #Internal medicine #Medicine #Oncology #Population #Tamoxifen

paper · doi:10.2165/00003495-200565180-00011

openalex publication_date 2005/01/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/29

Citations

• Goserelin

Cited by

• Drug repurposing for breast cancer therapy: Old weapon for new battle. [europepmc]
• Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer. [europepmc]
• Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer. [europepmc]
• Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats. [europepmc]
• A review of FDA approved drugs and their formulations for the treatment of breast cancer. [europepmc]
• Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions. [europepmc]
• Structural screening and molecular simulation identify potential ligands against the K700E hot spot variant and functional pockets of SF3B1 to modulate splicing in myelodysplastic syndrome. [europepmc]
• Rational Identification of Ritonavir as IL-20 Receptor A Ligand Endowed with Antiproliferative Properties in Breast Cancer Cells. [europepmc]
• The Use of Biologics for Targeting GPCRs in Metastatic Cancers. [europepmc]
• Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells. [europepmc]
• Effects of Different Gonadotropin-Releasing Hormone Agonists on IVF/ICSI-ET Outcomes in Long Protocol: A Retrospective Study. [europepmc]